Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta - PubMed (original) (raw)
. 2001 Sep 7;276(36):33471-7.
doi: 10.1074/jbc.M102839200. Epub 2001 Jun 20.
Affiliations
- PMID: 11418615
- DOI: 10.1074/jbc.M102839200
Free article
Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta
P Gervois et al. J Biol Chem. 2001.
Free article
Abstract
Fibrinogen is a coagulation factor and an acute phase reactant up-regulated by inflammatory cytokines, such as interleukin 6 (IL-6). Elevated plasma fibrinogen levels are associated with coronary heart diseases. Fibrates are clinically used hypolipidemic drugs that act via the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR alpha). In addition, most fibrates also reduce plasma fibrinogen levels, but the molecular mechanism is unknown. In this study, we demonstrate that fibrates decrease basal and IL-6-stimulated expression of the human fibrinogen-beta gene in human primary hepatocytes and hepatoma HepG2 cells. Fibrates diminish basal and IL-6-induced fibrinogen-beta promoter activity, and this effect is enhanced in the presence of co-transfected PPAR alpha. Site-directed mutagenesis experiments demonstrate that PPAR alpha activators decrease human fibrinogen-beta promoter activity via the CCAAT box/enhancer-binding protein (C/EBP) response element. Co-transfection of the transcriptional intermediary factor glucocorticoid receptor-interacting protein 1/transcriptional intermediary factor 2 (GRIP1/TIF2) enhances fibrinogen-beta gene transcription and alleviates the repressive effect of PPAR alpha. Co-immunoprecipitation experiments demonstrate that PPAR alpha and GRIP1/TIF2 physically interact in vivo in human liver. These data demonstrate that PPAR alpha agonists repress human fibrinogen gene expression by interference with the C/EBP beta pathway through titration of the coactivator GRIP1/TIF2. We observed that the anti-inflammatory action of PPAR alpha is not restricted to fibrinogen but also applies to other acute phase genes containing a C/EBP response element; it also occurs under conditions in which the stimulating action of IL-6 is potentiated by dexamethasone. These findings identify a novel molecular mechanism of negative gene regulation by PPAR alpha and reveal the direct implication of PPAR alpha in the modulation of the inflammatory gene response in the liver.
Similar articles
- Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation.
Kleemann R, Gervois PP, Verschuren L, Staels B, Princen HM, Kooistra T. Kleemann R, et al. Blood. 2003 Jan 15;101(2):545-51. doi: 10.1182/blood-2002-06-1762. Epub 2002 Aug 29. Blood. 2003. PMID: 12393563 - Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme.
Barbier O, Duran-Sandoval D, Pineda-Torra I, Kosykh V, Fruchart JC, Staels B. Barbier O, et al. J Biol Chem. 2003 Aug 29;278(35):32852-60. doi: 10.1074/jbc.M305361200. Epub 2003 Jun 16. J Biol Chem. 2003. PMID: 12810707 - Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
Chew CH, Chew GS, Najimudin N, Tengku-Muhammad TS. Chew CH, et al. Int J Biochem Cell Biol. 2007;39(10):1975-86. doi: 10.1016/j.biocel.2007.05.015. Epub 2007 May 31. Int J Biochem Cell Biol. 2007. PMID: 17616429 - Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
Fruchart JC, Duriez P, Staels B. Fruchart JC, et al. Curr Opin Lipidol. 1999 Jun;10(3):245-57. doi: 10.1097/00041433-199906000-00007. Curr Opin Lipidol. 1999. PMID: 10431661 Review. - The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).
Staels B, Schoonjans K, Fruchart JC, Auwerx J. Staels B, et al. Biochimie. 1997 Feb-Mar;79(2-3):95-9. doi: 10.1016/s0300-9084(97)81497-6. Biochimie. 1997. PMID: 9209702 Review.
Cited by
- Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.
Bieghs V, Wouters K, van Gorp PJ, Gijbels MJ, de Winther MP, Binder CJ, Lütjohann D, Febbraio M, Moore KJ, van Bilsen M, Hofker MH, Shiri-Sverdlov R. Bieghs V, et al. Gastroenterology. 2010 Jun;138(7):2477-86, 2486.e1-3. doi: 10.1053/j.gastro.2010.02.051. Epub 2010 Mar 2. Gastroenterology. 2010. PMID: 20206177 Free PMC article. - Unraveling the complex relationship triad between lipids, obesity, and inflammation.
Khan SA, Ali A, Khan SA, Zahran SA, Damanhouri G, Azhar E, Qadri I. Khan SA, et al. Mediators Inflamm. 2014;2014:502749. doi: 10.1155/2014/502749. Epub 2014 Aug 28. Mediators Inflamm. 2014. PMID: 25258478 Free PMC article. Review. - PPARα is regulated by miR-21 and miR-27b in human liver.
Kida K, Nakajima M, Mohri T, Oda Y, Takagi S, Fukami T, Yokoi T. Kida K, et al. Pharm Res. 2011 Oct;28(10):2467-76. doi: 10.1007/s11095-011-0473-y. Epub 2011 May 12. Pharm Res. 2011. PMID: 21562928 - The impact of PPARα activation on whole genome gene expression in human precision cut liver slices.
Janssen AW, Betzel B, Stoopen G, Berends FJ, Janssen IM, Peijnenburg AA, Kersten S. Janssen AW, et al. BMC Genomics. 2015 Oct 8;16:760. doi: 10.1186/s12864-015-1969-3. BMC Genomics. 2015. PMID: 26449539 Free PMC article. - Molecular pathways in non-alcoholic fatty liver disease.
Berlanga A, Guiu-Jurado E, Porras JA, Auguet T. Berlanga A, et al. Clin Exp Gastroenterol. 2014 Jul 5;7:221-39. doi: 10.2147/CEG.S62831. eCollection 2014. Clin Exp Gastroenterol. 2014. PMID: 25045276 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials